Logistic regression for HSES population. by Krystal Hunter (6820052)

Subjects:

Logistic regression for overall population. by Krystal Hunter (6820052)

Subjects:

BMISES_Data_Part1. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of HSES/LSES population. by Krystal Hunter (6820052)

Subjects:

Baseline characteristics of overall population. by Krystal Hunter (6820052)

Subjects:

Diagram of study population. by Krystal Hunter (6820052)

Subjects:

Determinants of uptake of maternity incentives by women who had a live birth one year prior to the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Determinant of delivery by CS for women who had a live birth in HF one year prior to the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…</p><p>Results</p><p>During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of −0.36% in HbA1c levels between the groups (95% CI: −0.54 – −0.19, P < 0.01). …”

Manhattan plot for genome-wide association study (GWAS) in a European population with depression. by Xiaomei He (795333)

“…<p>A: The x-axis represents the chromosomal position, and the y-axis represents the significance on a –log10 scale. …”

An infographic outlining the data used for each analysis. by Shelby L. Sturrock (10751675)

Subjects:

Experimental design. by Xueyan Lin (448667)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Alpha and beta diversity of gut microbiome. by Xueyan Lin (448667)

Subjects:

The expression of tight junction proteins in intestinal wall. by Xueyan Lin (448667)

Subjects:

BAEP, cognitive function, and ammonia levels in four groups. by Xueyan Lin (448667)

Subjects:

Rifaximin and lactulose on inflammation in MHE rats. by Xueyan Lin (448667)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Mean scores and 95% CI of mental health symptoms, COVID-19 admissions and effect size during follow-up. by A. H. Ayesha Lavell (16734002)